Characteristics of state prescription drug monitoring programs: a state-by-state survey

Pharmacoepidemiology and Drug Safety

Volumn 25, Issue 7, 2016, Pages 847-851

  Manasco, A Travis ^a   Griggs, Christopher ^b   Leeds, Rebecca ^c   Langlois, Breanne K ^a   Breaud, Alan H ^a   Mitchell, Patricia M ^d   Weiner, Scott G ^e  

^a BOSTON MEDICAL CENTER   (United States)

^b CAROLINAS MEDICAL CENTER   (United States)

^c TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

health policy; opioid abuse; pharmacoepidemiology; Prescription Drug Monitoring

Indexed keywords

CONTROLLED SUBSTANCE; PRESCRIPTION DRUG;

ARTICLE; DENTIST; DRUG MISUSE; DRUG MONITORING; DRUG SURVEILLANCE PROGRAM; HEALTH CARE POLICY; HEALTH SURVEY; HIGH RISK PATIENT; HUMAN; NURSE PRACTITIONER; PATIENT SAFETY; PHARMACIST; PHARMACOEPIDEMIOLOGY; PHARMACY; PHYSICIAN; PHYSICIAN ASSISTANT; PODIATRIST; PRESCRIPTION; PRIORITY JOURNAL; UNITED STATES; VETERINARIAN;

EID: 84977575423     PISSN: 10538569     EISSN: 10991557     Source Type: Journal    
DOI: 10.1002/pds.4003     Document Type: Article

References (21)

1. Kuehn BM. Poisonings top crashes for injury-related deaths. JAMA 2012; 307: 242.
2. U.S. DEA. Drug Control Policy. Epidemic: responding to America's prescription drug abuse crisis, 2011. https://www.whitehouse.gov/sites/default/files/ondcp/issues-content/prescription-drugs/rx_abuse_plan_0.pdf. Accessed 8/12/2015
3. Warner M, Chen LH, Makuc DM, et al. Drug Poisoning Deaths in the United States 1980-2008. National Center for Health Statistics Data Brief: Hyattsville, MD, 2011.
4. Gugelmann H, Perrone J, Nelson L. Windmills and pill mills: can PDMPs tilt the prescription drug epidemic? J Med Toxicol 2012; 8: 278–386.
5. Prescription Drug Monitoring Program Training and Technical Assistance Center. “Prescription Drug Monitoring FAQ.” PDMPassist.org. Accessed 3/05/2015
6. Griggs C, Weiner S, Feldman J. Prescription drug monitoring programs: examining limitations and future approaches. West J Emerg Med 2015; 16(1): 67–70.
7. Johnson H, Paulozzi L, Porucznik C, et al. Decline in drug overdose deaths after state policy changes - Florida, 2010-2012. MMWR Morb Mortal Wkly Rep 2014; 63(26): 569–74.
8. Florida PDMPMortal Wkly Rep. 2014;63(26):569‐74. Annual Report, 2012‐ 2013. Florida Department of Health Website. Available at: http://www.floridahealth.gov/reports- and‐data/e‐forcse/news‐reports/_documents/ 2012‐ 2013pdmp‐ annual‐report.pdf. Accessed Dec 1, 2014.
9. Virginia Prescription Monitoring Program. Statistics. Virginia Department of Health Professions Website, 2010. Available at: www.dhp. virginia.gov/dhp_programs/pmp/docs/ProgramStats/2010PMPStatsDec2010.pdf.
10. State/Territory/District Contacts. http://www.pdmpassist.org/node/400. Accessed March 5 2015.
11. Harris PA, Taylor R, Thielke R, Payne J, Gonzalez N, Conde JG. Research electronic data capture (REDCap)—a metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inform 2009; 42(2): 377–81.
12. Title 21 United States Code (USC) Controlled Substance Act. Section 812. Schedules of Controlled Substances. US Department of Justice. Drug Enforcement Administration. Office of Diversion Control. http://www.deadiversion.usdoj.gov/21cfr/21usc/812.htm. Accessed 5/22/2015
13. Haffajee R, Jena A, Weiner S. Mandatory use of prescription drug monitoring programs. JAMA 2015; 313(9): 891–2.
14. National Alliance for Model State Drug Laws. States that require prescribers and/or dispensers to access PMP databases in certain circumstances. http://www.namsdl.org/library/99E15A79-F594-42AA-8F8E61AF2C512CB4/. Accessed March 15, 2015.
15. Prescription Drug Monitoring Program Center of Excellence at Brandeis. COE briefing. http://www.pdmpexcellence.org/sites/all/pdfs/COE%20briefing%20on%20mandates%20revised_a.pdf. Accessed March 15, 2015.
16. Smith R, Kilaru A, Perrone J, et al. How, why, and for whom do emergency medicine providers use prescription drug monitoring programs? Pain Med. 2015 Jun;16(6): 1122–31.
17. Weiner S, Griggs C, Mitchell P, et al. Clinician impression versus prescription drug monitoring program criteria in the assessment of drug-seeking behavior in the emergency department. Ann Emerg Med 2013; 62(4): 281–9.
18. Centers for Disease Control Website, State Rx Drug Laws. Available at: http://www.cdc.gov/HomeandRecreationalSafety/Poisoning/laws/id_req.html. Accessed March 25, 2015.
19. Gwira JA, Wiedeman C, Dunn JR, et al. High-risk use by patients prescribed opioids for pain and its role in overdose deaths. JAMA Intern Med 2014; 174(5): 796–8.
20. McCarthy M. Hundreds of doctors to be investigated for questionable prescribing practices. BMJ 2013; 346: f4076.
21. Perrone JP, Nelson LS. Medication reconciliation for controlled substances: an “ideal” prescription-drug monitoring program. N Engl J Med 2012; 366(25): 2341–2343.